Straumann Holding AG EBITDA 2012-2024 | SAUHY

Straumann Holding AG annual and quarterly EBITDA history from 2012 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Straumann Holding AG EBITDA for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Straumann Holding AG EBITDA for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Straumann Holding AG 2024 annual EBITDA was $0.847B, a 40.55% increase from 2023.
  • Straumann Holding AG 2023 annual EBITDA was $0.603B, a 17.59% decline from 2022.
  • Straumann Holding AG 2022 annual EBITDA was $0.731B, a 3.53% increase from 2021.
Straumann Holding AG Annual EBITDA
(Millions of US $)
2024 $847
2023 $603
2022 $731
2021 $707
2020 $273
2019 $484
2018 $404
2017 $329
2016 $257
2015 $214
2014 $193
2013 $156
2012 $100
2011 $175
Straumann Holding AG Quarterly EBITDA
(Millions of US $)
2024-12-31
2023-12-31
2022-12-31
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2018-12-31
2017-12-31
2017-06-30
2016-12-31
2016-06-30
2015-12-31
2014-12-31
2013-12-31
2013-06-30
2012-12-31
2012-06-30
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.618B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.331B 21.81
Becton Dickinson (BDX) United States $48.715B 12.06
Cardinal Health (CAH) United States $39.527B 20.70
West Pharmaceutical Services (WST) United States $15.734B 32.98
Cooper (COO) United States $13.937B 17.96
Align Technology (ALGN) United States $13.608B 27.01
Henry Schein (HSIC) United States $8.904B 15.27
Merit Medical Systems (MMSI) United States $5.484B 26.51
DENTSPLY SIRONA (XRAY) United States $3.189B 9.52
CONMED (CNMD) United States $1.619B 12.12
STAAR Surgical (STAA) United States $0.834B 0.00
Lifevantage (LFVN) United States $0.162B 16.66
Pro-Dex (PDEX) United States $0.141B 15.40